Evidence level: B
韩国四象医学中”少阴人”对心源性栓塞性卒中(CES)表现出显著的遗传保护效应(β=−9.34),这个”低代谢、低血栓负荷”的保护表型,在中医九种体质中最可能对应的是阳虚质——但阳虚质并非少阴质的简单翻版,两者在凝血维度上存在关键分叉。
正文
一、一个罕见的”负向因果”信号
2024 年发表于 Biomedicines 的一项孟德尔随机化(MR)研究,用韩国基因组与流行病学队列(KoGES)的体质分型作为暴露、MEGASTROKE 等大型卒中联盟数据作为结局,检验了四象体质与卒中亚型的因果关联。结果出现了一个在体质研究中极为罕见的信号:少阴(So-eum)体质对心源性栓塞性卒中(CES)呈显著保护效应(β=−9.336,p=3.87×10⁻⁵),而太阴(Tae-eum)体质则呈风险效应(β=4.190,p=0.035)(PMID 38927518)。
这个结果本身不令人意外——四象医学的临床表型分层早就指向同一方向:少阴人体型消瘦(BMI 约 21),血糖、血脂、血压全线低于太阴人,糖尿病患病率仅 1.7%(太阴人 11.4%)(PMID 28865470)。14 年随访队列进一步确认,代谢综合征风险在四种体质中由高到低依次为太阴 > 少阳 > 少阴(PMID 28865470)。
但”少阴 → CES 保护”这个因果链,真正有意思的问题在于:中医的九种体质体系里,哪一个与少阴的保护表型同构?
二、CES 的风险核心:高凝与心房负担
要回答这个问题,先要看清 CES 的病理本质。CES 不是”血管堵了”,而是”心脏里掉出来的栓子把脑动脉堵了”——最常见来源是房颤心房内形成的血栓。因此 CES 的风险核心是两条:房颤的结构基础(左房扩大、瓣膜病变) 和 凝血倾向(高凝状态)。
这两条在遗传流行病学上都能找到独立证据。纤维蛋白原的遗传学研究表明,γ′ 纤维蛋白原异构体(具有抗凝特性)水平升高对 CES 和大动脉卒中呈保护效应(PMID 33367543);而总体纤维蛋白原水平每升高 1 g/L,缺血性卒中风险因果性翻倍(OR 2.28)(PMID 39674435)。换句话说:凝血偏”低”的人,CES 风险就偏”低”——少阴人的保护信号,遗传上落在”低代谢-低房颤负荷-低凝”这一整块表型上。
三、三选一:阳虚、阴虚、气虚,谁更像少阴?
按中医理论框架,少阴人的核心特征是”里寒而外温、形瘦而气清”——能量代谢偏低的”寒性”表型。在九种体质中,候选者有三个:阳虚质、阴虚质、气虚质。
先排除气虚质。 中医体质与缺血性卒中的系统综述与 meta 分析(41 项研究、11211 名参与者)显示:气虚质在缺血性卒中患者中占比 25%,是普通人群的 3.47 倍(OR 3.47)——气虚质是卒中的高风险体质,与少阴的保护方向正好相反(PMID 34257683)。气虚的机制是”无力帅血”导致血流瘀滞,这在病理上是促栓而非抗栓,与少阴不兼容。
再审视阴虚质。 阴虚质确实有低 BMI、形体偏瘦的一面,与少阴形似;但阴虚的核心病理是”阳亢化风”——中医经典认为阴虚者阳气易张、风阳上扰,是卒中发病的”火”性内因。临床数据显示,缺血性卒中患者中阳虚质入院时血浆 BNP 水平最高(提示心房/心室负荷重),阴虚质则与高炎性状态相关。阴虚质的”瘦”伴随的是亢进性代谢信号,与少阴的”低代谢保护”表型在方向上相反。
最后看阳虚质——最强候选。 三层证据叠合:
1. 能量代谢维度:阳虚质白细胞线粒体氧耗率(OCR)、ATP 含量显著低于平和质(PMID 36749256);阳虚质外周血中甲状腺激素受体 β(TRβ)及核受体共激活因子表达下调,产热通路受损(PMID 19051350)——这是”低代谢”的分子底座,与少阴的 BMI/血脂全面偏低同构。
2. 代谢保护维度:阳虚质血清呈现葡萄糖、谷氨酰胺、HDL 升高而脂质、VLDL/LDL、游离脂肪酸降低的谱型——即”血脂负荷低、能量代谢慢”,这与少阴在代谢综合征风险谱中的最末位(PMID 28865470)指向同一表型区间。
3. 中医病机维度:阳虚”温煦推动无力”,在卒中的整体风险框架中与气虚同属”虚”类,但阳虚的临床表型(畏寒、肢冷、脉沉迟)更接近四象医学对少阴人”里寒”的描述。
四、关键分叉:阳虚 ≠ 少阴
然而,”同构”不等于”相同”。最大的不确定性在凝血维度:
- 少阴的保护效应(β=−9.34)是全表型遗传信号对 CES 的净因果效应,其中隐含了”低凝”成分;
- 而阳虚质的低代谢是”慢”,慢本身不必然等于”抗栓”——低体温、低血流剪切力理论上还可能增加凝血倾向。阳虚质的高纤维蛋白原状态是否抵消其代谢保护,现有数据无法回答。
这正是本课题的裁决点:阳虚质的 MR 效应方向是否真的为负? 若为负,其量级是否与少阴(β=−9.34)可比?需要阳虚质 GWAS 汇总统计量 × CES GWAS 的双样本 MR 来实证;同时用纤维蛋白原、凝血因子 XI 等中间表型做 MR 中介分析,拆解”代谢保护通道”与”凝血通道”各自贡献的方向与大小。
五、为什么这个甄别有意义?
如果实证确认阳虚质与少阴的保护表型同构,将带来两个直接推论:其一,中医体质体系的”阳虚”与四象医学的”少阴”在遗传-代谢层面首次实现跨体系锚定,为两个传统医学体系的融合提供可检验的桥桩;其二,房颤高风险人群(老年人、高血压患者)中,阳虚质的抗栓获益-出血风险权衡可能不同于其他体质——这直接关系到抗凝决策的个体化。但在这之前,一切仍停留于假设:证据等级为 B,靠的是跨体系的表型类比与机制链条,而非同一体系内的直接因果证据。
证据与局限
已验证: 四象医学中少阴体质对 CES 呈显著保护因果效应(β=−9.336,PMID 38927518);少阴体质在代谢综合征/糖尿病风险谱中最低(PMID 28865470);中医缺血性卒中患者中气虚质占比最高(25%,OR 3.47,PMID 34257683);阳虚质线粒体能量代谢显著低于平和质(PMID 36749256);纤维蛋白原与缺血性卒中呈因果正相关(PMID 39674435)。
部分验证: 阳虚质血清代谢谱(HDL 高、脂质低)与少阴”低代谢保护”表型同向(PMID 19051350 及代谢组学证据);γ′ 纤维蛋白原对 CES 的保护效应提示”低凝”是 CES 保护的可遗传通道(PMID 33367543)。
待验证: 阳虚/阴虚/气虚三质 GWAS × CES GWAS 逐质双样本 MR 的效应方向与量级(是否复现负向且与 β=−9.34 可比);阳虚质的高凝通道是否抵消其代谢保护(纤维蛋白原/凝血因子中介分析);”阳虚↔少阴”跨体系锚定在东亚其他人群(中国 CKB 队列)的可复现性。
相关阅读
证据等级: B(科学类比/间接证据——四象医学侧有直接 MR 证据,九种体质对应侧为机制类比)
参考文献: PMID 38927518, PMID 34257683, PMID 36749256, PMID 28865470, PMID 19051350, PMID 33367543, PMID 39674435
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Protective Effect of Yinmin Constitution on Cardiac Embolic Stroke: Correspondence Among the Nine Traditional Chinese Medicine Constitutions
Evidence level: B
In Korean Sasang medicine, individuals with the So-eum constitution exhibit a significant genetic protective effect against cardioembolic stroke (CES) ($\beta = -9.34$). This “low-metabolism, low-thrombus-burden” phenotype is most likely analogous to the Yang Xu constitution in the nine TCM constitutions; however, Yang Xu is not a simple replica of So-eum, with a critical divergence observed in the coagulation dimension.
Main Text
I. A Rare “Negative Causal” Signal
A 2024 Mendelian randomization (MR) study published in Biomedicines utilized Sasang constitution phenotyping from the KoGES Korean genomic and epidemiological cohort as the exposure and large-scale stroke consortium data (e.g., MEGASTROKE) as the outcome to test causal associations between Sasang constitutions and stroke subtypes. The results revealed a signal highly unusual in constitution research: So-eum constitution showed a significant protective effect against CES ($\beta = -9.336$, $p = 3.87 \times 10^{-5}$), whereas Tae-eum constitution showed a risk effect ($\beta = 4.190$, $p = 0.035$) (PMID 38927518).
This finding itself is not unexpected—the clinical phenotypic stratification in Sasang medicine has long pointed in the same direction: So-eum individuals have a leaner body type (BMI $\approx$ 21), with blood glucose, lipids, and blood pressure all lower than Tae-eum individuals; the prevalence of diabetes is only 1.7% (compared to 11.4% in Tae-eum) (PMID 28865470). A 14-year follow-up cohort further confirmed that metabolic syndrome risk across the four constitutions follows the order Tae-eum > So-yang > So-eum (PMID 28865470).
However, the causal chain “So-eum $\rightarrow$ CES protection” raises a more interesting question: Which of the nine TCM constitutions is isomorphic to the protective phenotype of So-eum?
II. The Risk Core of CES: Hypercoagulability and Atrial Burden
To answer this, one must first clarify the pathological essence of CES. CES is not merely “blocked vessels,” but rather “emboli shed from the heart block cerebral arteries”—the most common source being thrombi formed within the atria due to atrial fibrillation. Thus, the risk core of CES rests on two factors: structural basis for atrial fibrillation (left atrial enlargement, valvular disease) and coagulation tendency (hypercoagulable state).
Independent evidence for both factors can be found in genetic epidemiology. Genetic studies on fibrinogen indicate that elevated levels of the $\gamma’$ fibrinogen isoform (which possesses anticoagulant properties) exert a protective effect against CES and large-artery stroke (PMID 33367543); conversely, for every 1 g/L increase in total fibrinogen levels, the causal risk of ischemic stroke doubles (OR 2.28) (PMID 39674435). In other words: Individuals with lower coagulation bias have lower CES risk—the protective signal in So-eum individuals genetically falls on the entire phenotype block of “low metabolism-low atrial burden-low coagulation.”
III. Three Candidates: Yang Xu, Yin Xu, or Qi Xu?
Within the TCM theoretical framework, the core characteristics of So-eum individuals are “internal cold with external warmth, lean form with clear qi”—a “cold” phenotype characterized by lower energy metabolism. Among the nine constitutions, there are three candidates: Yang Xu, Yin Xu, and Qi Xu.
First, exclude Qi Xu. A systematic review and meta-analysis (41 studies, 11,211 participants) on TCM constitutions and ischemic stroke shows that Qi Xu constitutes 25% of ischemic stroke patients, which is 3.47 times the general population (OR 3.47)—Qi Xu is a high-risk constitution for stroke, directly opposite to the protective direction of So-eum (PMID 34257683). The mechanism of Qi Xu is “inability to command blood,” leading to stasis; pathologically, this promotes thrombosis rather than anticoagulation, which is incompatible with So-eum.
Next, re-examine Yin Xu. Yin Xu does share the low BMI and lean form with So-eum; however, the core pathology of Yin Xu is “yang hyperactivity transforming into wind.” Traditional TCM classics posit that individuals with Yin Xu have easily rising yang and wind disturbing upward, representing the “fire” internal etiology for stroke onset. Clinical data indicates that among ischemic stroke patients, Yang Xu has the highest plasma BNP levels upon admission (indicating heavy atrial/ventricular burden), while Yin Xu is associated with a high inflammatory state. The “leanness” of Yin Xu accompanies hyperactive metabolic signals, which are opposite in direction to So-eum’s “low-metabolism protective” phenotype.
Finally, examine Yang Xu—the strongest candidate. Three layers of evidence converge:
1. Energy metabolism dimension: Yang Xu individuals show significantly lower white blood cell mitochondrial oxygen consumption rate (OCR) and ATP content compared to the Heping constitution (PMID 36749256); expression of thyroid hormone receptor $\beta$ (TR$\beta$) and nuclear receptor coactivators is downregulated in peripheral blood of Yang Xu, indicating damage to thermogenesis pathways (PMID 19051350)—this constitutes the molecular foundation of “low metabolism,” isomorphic to So-eum’s comprehensive low BMI and lipids.
2. Metabolic protection dimension: Yang Xu serum profiles show elevated glucose, glutamine, and HDL, coupled with reduced lipids, VLDL/LDL, and free fatty acids—a pattern of “low lipid burden, slow energy metabolism,” which aligns with So-eum’s position at the lowest end of metabolic syndrome risk spectra (PMID 28865470).
3. TCM pathogenesis dimension: Yang Xu’s “inadequate warming and propulsion” belongs to the “deficiency” category alongside Qi Xu in the overall stroke risk framework; however, the clinical phenotype of Yang Xu (aversion to cold, cold limbs, deep and slow pulse) more closely matches Sasang medicine’s description of So-eum as “internal cold.”
IV. Critical Divergence: Yang Xu $\neq$ So-eum
However, “isomorphism” does not equal “identity.” The greatest uncertainty lies in the coagulation dimension:
- So-eum’s protective effect ($\beta = -9.34$) is a net causal effect of the entire phenotype on CES, implicitly containing a “low coagulation” component;
- Conversely, the low metabolism of Yang Xu is simply “slow,” and slowness does not necessarily equal “anticoagulation”—low body temperature and low blood flow shear force theoretically could still increase coagulation tendency. Whether the high fibrinogen state in Yang Xu offsets its metabolic protection remains unanswered by existing data.
This is the adjudication point of this topic: Is the MR effect direction for Yang Xu truly negative? If so, does its magnitude compare to So-eum ($\beta = -9.34$)? Empirical verification requires a two-sample MR using Yang Xu GWAS summary statistics $\times$ CES GWAS; simultaneously, intermediate phenotypes such as fibrinogen and coagulation factor XI should be used for MR mediation analysis to decompose the directional and magnitude contributions of the “metabolic protection pathway” versus the “coagulation pathway.”
V. Why Is This Discrimination Significant?
If empirical confirmation establishes isomorphism between Yang Xu and So-eum protective phenotypes, two direct implications arise: First, the TCM “Yang Xu” and Sasang “So-eum” would achieve the first cross-system anchoring in genetic-metabolic levels, providing a testable bridge for the integration of these two traditional medical systems; Second, in high-risk atrial fibrillation populations (elderly, hypertensive patients), the trade-off between anticoagulant benefit and bleeding risk for Yang Xu may differ from other constitutions—directly impacting individualized anticoagulation decisions. However, prior to this, everything remains at the hypothesis stage: Evidence level is B, relying on cross-system phenotypic analogy and mechanistic chains rather than direct causal evidence within a single system.
Evidence and Limitations
Verified: Significant protective causal effect of So-eum constitution on CES ($\beta = -9.336$, PMID 38927518); So-eum constitution at the lowest end of metabolic syndrome/diabetes risk spectra (PMID 28865470); Qi Xu has the highest proportion among ischemic stroke patients in TCM (25%, OR 3.47, PMID 34257683); Yang Xu mitochondrial energy metabolism significantly lower than Heping (PMID 36749256); Fibrinogen shows causal positive correlation with ischemic stroke (PMID 39674435).
Partially Verified: Yang Xu serum metabolic profile (high HDL, low lipids) aligns directionally with So-eum “low-metabolism protective” phenotype (PMID 19051350 and metabolomics evidence); $\gamma’$ fibrinogen protective effect against CES suggests “low coagulation” is a heritable channel for CES protection (PMID 33367543).
To be Verified: Effect direction and magnitude of per-constitution two-sample MR using Yang Xu/Yin Xu/Qi Xu GWAS $\times$ CES GWAS (whether negative effect is replicated and comparable to $\beta = -9.34$); Whether the high coagulation channel in Yang Xu offsets its metabolic protection (fibrinogen/coagulation factor mediation analysis); Replicability of cross-system anchoring “Yang Xu $\leftrightarrow$ So-eum” in other East Asian populations (e.g., China CKB cohort).
Related Reading
- Cross-system causal bridging between Sasang and TCM constitutions: So-eum-Taiyin CES replication adjudication
- Cross-population replication of CES causal chain mapping phlegm constitution to Taiyin
- Constitution Genetics: GWAS and Mendelian Randomization Roadmap
- Research Pool: Bio-frequency Code
Evidence Level: B (Scientific analogy/indirect evidence—direct MR evidence exists on the Sasang side, while the nine constitution correspondence relies on mechanistic analogy)
References: PMID 38927518, PMID 34257683, PMID 36749256, PMID 28865470, PMID 19051350, PMID 33367543, PMID 39674435
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply